Skip to main content
Premium Trial:

Request an Annual Quote

BD To Pay Quarterly Dividend, Repurchase Shares

NEW YORK (GenomeWeb News) – Becton Dickinson today said that its board of directors has declared a quarterly dividend of $.33 per common share.
The dividend is payable on Jan. 2, 2009, to shareholders of record on Dec. 12, 2008. The dividend is $.045 more than the dividend for the previous quarter, said BD. At the current rate, BD’s annual dividend would be $1.32 per share.
In addition to the dividend, the firm said that the board also authorized the repurchase of up to 10 million common shares. The new repurchase program is in addition to the 5.9 million shares that remained available on Sept. 30, under a 10-million share repurchase program authorized in July 2007.
BD had roughly 243 million shares outstanding as of Sept. 30.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more